U.S. Research Antibodies Market Size & Outlook, 2023-2030
U.S. research antibodies market, 2018-2030 (US$M)
Related Markets
U.S. research antibodies market highlights
- The U.S. research antibodies market generated a revenue of USD 559.1 million in 2023 and is expected to reach USD 749.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, primary was the largest revenue generating product in 2023.
- Primary is the most lucrative product segment registering the fastest growth during the forecast period.
Research antibodies market data book summary
| Market revenue in 2023 | USD 559.1 million |
| Market revenue in 2030 | USD 749.2 million |
| Growth rate | 4.3% (CAGR from 2023 to 2030) |
| Largest segment | Primary |
| Fastest growing segment | Primary |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary, Secondary |
| Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.1% of the global research antibodies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. research antibodies market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 125.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research Antibodies Market Scope
Research Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. research antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research antibodies market will help companies and investors design strategic landscapes.
Primary was the largest segment with a revenue share of 74.1% in 2023. Horizon Databook has segmented the U.S. research antibodies market based on primary, secondary covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. dominated the overall North America research antibodies market in terms of revenue share in 2019. Increasing focus on biomedical, stem cells, and cancer research is a key factor contributing toward its high market share.
The rising prevalence of chronic diseases such as cardiovascular & blood diseases is expected to fuel market growth. The same source states that one in 6 women and one in 5 men can develop cancer during their lifetime. Thus, there is increasing focus on cancer research and stem cell research activities.
Stem cell therapy is the most promising technique to treat severe medical conditions including cancer and blood diseases. Thus, the biotechnology and biopharmaceutical companies are adopting advanced research antibodies products for stem cells research, which is projected to drive the market growth.
Reasons to subscribe to U.S. research antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. research antibodies market databook
-
Our clientele includes a mix of research antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. research antibodies market , including forecasts for subscribers. This country databook contains high-level insights into U.S. research antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. research antibodies market size, by product, 2018-2030 (US$M)
U.S. Research Antibodies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
